MedTrace Logo

Procalcitonin-Guided Antibiotic Therapy in Bronchiectasis

NCT03058718 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2017-02-23

No results posted yet for this study

Summary

To explore effectiveness of procalcitonin-guided antibiotic therapy in acute exacerbations of bronchiectasis, and to explore the clinical value of procalcitonin in bronchiectasis.

Conditions

Interventions

OTHER

Procalcitonin

The application of antimicrobial agents is determined by PCT results.

OTHER

Clinical Experience

The application of antimicrobial agents is determined by clinical experience of doctors.

Sponsors & Collaborators

  • Qilu Hospital of Shandong University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2016-07-01
Completion
2017-02-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03058718 on ClinicalTrials.gov